We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

188 hedge funds and large institutions have $370M invested in SANGAMO THERAPEUTICS INC in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 74 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more call options, than puts

Call options by funds: $2.56M | Put options by funds: $1.54M

61% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 46

6.98% more ownership

Funds ownership: 54.16% → 61.14% (+7%)

4% less funds holding

Funds holding: 195 → 188 (-7)

14% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 21

19% less capital invested

Capital invested by funds: $458M → $370M (-$87.4M)

Holders
188
Holders Change
-7
Holders Change %
-3.59%
% of All Funds
3.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
74
Reduced
46
Closed
21
Calls
$2.56M
Puts
$1.54M
Net Calls
+$1.02M
Net Calls Change
-$672K

Top Buyers

Rank Fund Capital Flow
1
RCMU
Rokos Capital Management (UK)
United Kingdom
+$8.86M
2
WA
Wasatch Advisors
Utah
+$7.85M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$6.01M
4
CC
Casdin Capital
New York
+$4.32M
5
BlackRock
BlackRock
New York
+$3.25M

Top Sellers

Rank Fund Capital Flow
1
GLA
Great Lakes Advisors
Illinois
-$3.04M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$1.53M
3
PAM
Panagora Asset Management
Massachusetts
-$1.16M
4
UBS Group
UBS Group
Switzerland
-$1.14M
5
CI Investments Inc
CI Investments Inc
Ontario, Canada
-$875K
Name Holding Trade Value Shares
Change 		Change in
Stake
BWM
176
Baystate Wealth Management
Massachusetts
$1K – – –
GWMI
177
Guardian Wealth Management (Illinois)
Illinois
$1K – – –
National Bank of Canada
178
National Bank of Canada
Quebec, Canada
$1K – – –
UB
179
UMB Bank
Missouri
$1K – – –
BPC
180
Banque Pictet & Cie
Switzerland
$683 -$68.7K -15,896 -9%
ECM
181
Estabrook Capital Management
New York
$58 – – –
Bank of Montreal
182
Bank of Montreal
Ontario, Canada
$46 +$3.44K +796 +7%
WIM
183
Westside Investment Management
California
$2 – – –
GLA
184
Great Lakes Advisors
Illinois
– -$3.04M -523,194 Closed
PAM
185
Panagora Asset Management
Massachusetts
– -$1.16M -199,945 Closed
CI Investments Inc
186
CI Investments Inc
Ontario, Canada
– -$875K -150,653 Closed
Massachusetts Financial Services
187
Massachusetts Financial Services
Massachusetts
– -$711K -122,387 Closed
EGM
188
Engineers Gate Manager
New York
– -$294K -50,600 Closed
SEI Investments
189
SEI Investments
Pennsylvania
– -$61K -20,635 Closed
ACM
190
AlphaCrest Capital Management
New York
– -$84K -14,419 Closed
Walleye Trading
191
Walleye Trading
New York
– -$56K -9,715 Closed
ACM
192
Aquatic Capital Management
Illinois
– -$19K -3,300 Closed
AWA
193
Aaron Wealth Advisors
Illinois
– -$523K -3,038 Closed
Nisa Investment Advisors
194
Nisa Investment Advisors
Missouri
– -$17K -3,000 Closed
Optiver Holding
195
Optiver Holding
Netherlands
– -$8K -1,442 Closed
BG
196
Bollard Group
Massachusetts
– -$7K -1,273 Closed
BFC
197
Bedel Financial Consulting
Indiana
– -$4K -730 Closed
BC
198
Bartlett & Co
Ohio
– -$3K -600 Closed
BCWM
199
Bartlett & Co Wealth Management
Ohio
– -$3.49K -600 Closed
EWA
200
EverSource Wealth Advisors
Alabama
– -$2K -328 Closed
5 6 7
8
9

SGMO Hedge Fund Activity: Q2 2022 in Review

188 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2022, worth a combined $370M — down 19% from $458M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of SGMO and 18 opened new positions — a net loss of 3 holders — while 46 trimmed existing stakes and 74 added.

The largest buyer was Rokos Capital Management (UK), adding an estimated $8.86M. The largest seller was Great Lakes Advisors, exiting entirely with an estimated $3.04M sold.

  • 188 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2022, down from 195 in Q1 2022.
  • Funds reported $370M of SANGAMO THERAPEUTICS INC stock for Q2 2022, down 19% quarter-over-quarter.
  • 18 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2022 and 21 closed out, a net change of -3 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2022 was Rokos Capital Management (UK), an estimated $8.86M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2022 was Great Lakes Advisors, an estimated $3.04M sold.

Based on aggregated 13F filings for Q2 2022.